164 related articles for article (PubMed ID: 29610507)
1. Vedolizumab as a Novel Treatment for Refractory Collagenous Colitis: A Case Report.
Cushing KC; Mino-Kenudson M; Garber J; Lochhead P; Khalili H
Am J Gastroenterol; 2018 Apr; 113(4):632-633. PubMed ID: 29610507
[No Abstract] [Full Text] [Related]
2. Vedolizumab in Refractory Microscopic Colitis: An International Case Series.
Rivière P; Münch A; Michetti P; Chande N; de Hertogh G; Schoeters P; Ferrante M; Vermeire S; Van Assche G
J Crohns Colitis; 2019 Mar; 13(3):337-340. PubMed ID: 30329034
[TBL] [Abstract][Full Text] [Related]
3. Vedolizumab for refractory collagenous colitis: Another piece of the puzzle.
Casper M; Zimmer V; Hübschen U; Lammert F
Dig Liver Dis; 2018 Oct; 50(10):1099-1100. PubMed ID: 30115575
[No Abstract] [Full Text] [Related]
4. Adalimumab in budesonide and methotrexate refractory collagenous colitis.
Münch A; Ignatova S; Ström M
Scand J Gastroenterol; 2012 Jan; 47(1):59-63. PubMed ID: 22149977
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of anti-TNF therapies in refractory severe microscopic colitis.
Esteve M; Mahadevan U; Sainz E; Rodriguez E; Salas A; Fernández-Bañares F
J Crohns Colitis; 2011 Dec; 5(6):612-8. PubMed ID: 22115383
[TBL] [Abstract][Full Text] [Related]
6. Successful use of infliximab in the treatment of corticosteroid dependent collagenous colitis.
Pola S; Fahmy M; Evans E; Tipps A; Sandborn WJ
Am J Gastroenterol; 2013 May; 108(5):857-8. PubMed ID: 23644970
[No Abstract] [Full Text] [Related]
7. Successful Vedolizumab Therapy in a Sixteen-Year-Old Boy with Refractory Ulcerative Colitis.
Zoet ID; de Boer NK; de Meij TG
J Crohns Colitis; 2016 Mar; 10(3):373-4. PubMed ID: 26574489
[No Abstract] [Full Text] [Related]
8. Vedolizumab-Induced Remission in 3 Patients With Refractory Microscopic Colitis: A Tertiary Care Center Case Series.
Jennings JJ; Charabaty A
Inflamm Bowel Dis; 2019 Jul; 25(8):e97. PubMed ID: 30889247
[No Abstract] [Full Text] [Related]
9. Vedolizumab: a novel treatment for ipilimumab-induced colitis.
Hsieh AH; Ferman M; Brown MP; Andrews JM
BMJ Case Rep; 2016 Aug; 2016():. PubMed ID: 27539137
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Vedolizumab in Patients with Antibiotic and Anti-tumor Necrosis Alpha Refractory Pouchitis.
Philpott J; Ashburn J; Shen B
Inflamm Bowel Dis; 2017 Jan; 23(1):E5-E6. PubMed ID: 27930413
[No Abstract] [Full Text] [Related]
11. Vedolizumab and Infliximab Combination Therapy in the Treatment of Crohn's Disease.
Hirten R; Longman RS; Bosworth BP; Steinlauf A; Scherl E
Am J Gastroenterol; 2015 Dec; 110(12):1737-8. PubMed ID: 26673509
[No Abstract] [Full Text] [Related]
12. Pharmacodynamic assessment of vedolizumab for the treatment of ulcerative colitis.
McLean LP; Cross RK
Expert Opin Drug Metab Toxicol; 2016 Jul; 12(7):833-42. PubMed ID: 27096357
[TBL] [Abstract][Full Text] [Related]
13. Recurrent COVID-19 in a Patient With Ulcerative Colitis on Vedolizumab Therapy.
Crouwel F; Waaijenberg-Warmenhoven P; Buiter HJC; de Boer NK
J Crohns Colitis; 2021 Jul; 15(7):1244-1245. PubMed ID: 33350449
[No Abstract] [Full Text] [Related]
14. Efficacy of budesonide in collagenous colitis Evaluation of: Miehlke S, Madisch A, Kupcinskas L, et al. Budesonide is more effective than mesalamine or placebo in short-term treatment of collagenous colitis. Gastroenterology 2014;146(5):1222-1230 e1222.
Drug VL; Antoniu SA
Expert Opin Pharmacother; 2014 Oct; 15(15):2277-9. PubMed ID: 25164577
[TBL] [Abstract][Full Text] [Related]
15. Patients with drug-induced microscopic colitis should not be included in controlled trials assessing the efficacy of anti-inflammatory drugs in microscopic colitis.
Beaugerie L; Pardi DS
Gastroenterology; 2009 Oct; 137(4):1535-6. PubMed ID: 19717133
[No Abstract] [Full Text] [Related]
16. A review of the cost-effectiveness of vedolizumab for treating moderate- to severely active ulcerative colitis.
Tsai HH; Black C
Expert Rev Pharmacoecon Outcomes Res; 2016 Dec; 16(6):679-683. PubMed ID: 27726457
[TBL] [Abstract][Full Text] [Related]
17. A Case of Vedolizumab-induced Acute Allergic Reaction in a Patient With Refractory Ulcerative Colitis.
Xie Y; Li H; Zhou L; Tian F
Inflamm Bowel Dis; 2022 Jul; 28(7):e103. PubMed ID: 35134937
[No Abstract] [Full Text] [Related]
18. Efficacy and safety of vedolizumab as a treatment option for moderate to severe refractory ulcerative colitis in two patients after liver transplant due to primary sclerosing cholangitis.
Olmedo Martín RV; Amo Trillo V; González Grande R; Jiménez Pérez M
Rev Esp Enferm Dig; 2017 Sep; 109(9):659-662. PubMed ID: 28724302
[TBL] [Abstract][Full Text] [Related]
19. Vedolizumab treatment for immune checkpoint inhibitor-induced enterocolitis.
Bergqvist V; Hertervig E; Gedeon P; Kopljar M; Griph H; Kinhult S; Carneiro A; Marsal J
Cancer Immunol Immunother; 2017 May; 66(5):581-592. PubMed ID: 28204866
[TBL] [Abstract][Full Text] [Related]
20. Letter: Vedolizumab in Pregnancy.
Sheridan J; Cullen G; Doherty G
J Crohns Colitis; 2017 Aug; 11(8):1025-1026. PubMed ID: 27993997
[No Abstract] [Full Text] [Related]
[Next] [New Search]
